Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma

Chemotherapy is among the limited choices approved for the treatment of hepatocellular carcinoma (HCC) at intermediate and advanced stages. Preferential and prolonged drug exposure in diseased sites is required to maximize the therapeutic index of the drug. Here, we report an injectable supramolecul...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Acta Pharm Sin B
Auteurs principaux: Zhao, Xiyue, Liu, Xiaoyu, Zhang, Pengcheng, Liu, Yiran, Ran, Wei, Cai, Ying, Wang, Junyang, Zhai, Yihui, Wang, Guanru, Ding, Yaping, Li, Yaping
Format: Artigo
Langue:Inglês
Publié: Elsevier 2019
Sujets:
Original article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804453/
https://ncbi.nlm.nih.gov/pubmed/31649853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2019.06.001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires